Comunicação em evento científico
Substitutability between drugs, innovation and growth in the pharmaceutical industry
Sofia Vale (Vale, S.); Felipa Sampayo (de Mello-Sampayo, F.); Francisco Camões (Camões, F.);
Título Evento
10th Eurasia Business and Economics Society
Ano (publicação definitiva)
2013
Língua
Inglês
País
Turquia
Mais Informação
--
Web of Science®

Esta publicação não está indexada na Web of Science®

Scopus

Esta publicação não está indexada na Scopus

Google Scholar

N.º de citações: 0

(Última verificação: 2024-10-07 02:04)

Ver o registo no Google Scholar

Abstract/Resumo
This paper establishes a relationship between the elasticity of demand for pharmaceutical intermediates and the growth rate for these interme- diates variety. We build a model that contains two sectors, one nal good sector producing treatments, and one intermediate goods sector produc- ing a di erentiated input used in the nal treatment. The e ects on the medicaments varieties' growth rate of the introduction of a scal in- strument over pharmaceutical producers' pro ts are discussed. When the scal instrument is a tax over intermediate rms' pro ts, R&D by rms in the pharmaceutical goods sector results in positive growth provided pro- vided there exists enough substitutability among intermediates assured by a patent system. Otherwise, a subsidy over pharmaceutical rms' pro ts should be considered to generate positive growth of innovation in medica- ments
Agradecimentos/Acknowledgements
--
Palavras-chave